Prednisone (or Prednisolone)
Showing 1 - 25 of >10,000
Pharmacokinetics of Glucocorticoids in Children (GLUCOPED)
Active, not recruiting
- Children Receiving Prednisone or Prednisolone or Methylprednisolone or Hydrocortisone
- Pharmacokinetic
-
Paris, FranceAP-HP Necker
Sep 20, 2022
Follicular Lymphoma (FL) Trial (biological, drug, other)
Not yet recruiting
- Follicular Lymphoma (FL)
- Tisagenlecleucel
- +4 more
- (no location specified)
May 24, 2023
Uveitis Trial in United States (Izokibep, Prednisone/Prednisolone)
Active, not recruiting
- Uveitis
-
Los Angeles, California
- +3 more
Jul 18, 2022
Thrombotic Thrombocytopenic Purpura Trial (Caplacizumab, Corticosteroids, anti-CD20 antibody)
Not yet recruiting
- Thrombotic Thrombocytopenic Purpura
- Caplacizumab
- +2 more
- (no location specified)
Aug 8, 2022
Hepatitis, Drug-Induced Trial in Denmark (Mycophenolate Mofetil, Tacrolimus, Solu-Medrol)
Recruiting
- Hepatitis, Drug-Induced
- Mycophenolate Mofetil
- +3 more
-
Herlev, Copenhagen, Denmark
- +4 more
Dec 11, 2022
Cardiac Sarcoidosis, Sarcoidosis Trial in Worldwide (Prednisone or Prednisolone, Methotrexate)
Recruiting
- Cardiac Sarcoidosis
- Sarcoidosis
- Prednisone or Prednisolone
- Methotrexate
-
New Haven, Connecticut
- +17 more
Oct 18, 2021
Rheumatoid Arthritis Trial in Ann Arbor (Oral prednisone Taper)
Recruiting
- Rheumatoid Arthritis
- Oral prednisone Taper
-
Ann Arbor, MichiganVA Ann Arbor Healthcare System, Ann Arbor, MI
Oct 2, 2023
Lymphoma, Large B-Cell, Diffuse (DLBCL) Trial in Jerusalem, Seoul, Warszawa (Zilovertamab Vedotin, Cyclophosphamide,
Recruiting
- Lymphoma, Large B-Cell, Diffuse (DLBCL)
- Zilovertamab Vedotin
- +6 more
-
Victoria, British Columbia, Canada
- +19 more
Jan 19, 2023
Recurrent Acute Leukemia of Ambiguous Lineage, Recurrent Acute Lymphoblastic Leukemia, Recurrent Mixed Phenotype Acute Leukemia
Not yet recruiting
- Recurrent Acute Leukemia of Ambiguous Lineage
- +5 more
- Biospecimen Collection
- +12 more
- (no location specified)
Mar 8, 2023
Lymphoma, Large B-Cell, Diffuse Trial in Worldwide (Durvalumab, Rituximab, Doxorubicin)
Metastatic Prostate Cancer Trial in Worldwide (Ipatasertib, Abiraterone, Placebo)
Active, not recruiting
- Metastatic Prostate Cancer
- Ipatasertib
- +3 more
-
Chandler, Arizona
- +183 more
Nov 24, 2022
IgA Nephropathy, Proteinuria in Nephrotic Range, Immunosuppressive Treatment Trial in Beijing (Corticosteroid, Cyclophosphamide,
Recruiting
- IgA Nephropathy
- +2 more
- Corticosteroid
- +4 more
-
Beijing, ChinaPeking University First Hospital
Apr 21, 2022
Steroid-Sensitive Nephrotic Syndrome Trial in Shanghai (Rituximab, Corticosteroid)
Not yet recruiting
- Steroid-Sensitive Nephrotic Syndrome
-
Shanghai, Shanghai, China
- +2 more
May 6, 2023
Lymphoma, Lymphoma, Large B-Cell, Diffuse Trial in Boston (Glofitamab, Polatuzumab, Rituximab)
Not yet recruiting
- Lymphoma
- Lymphoma, Large B-Cell, Diffuse
- Glofitamab
- +5 more
-
Boston, Massachusetts
- +1 more
Apr 4, 2023
Focal Cerebral Arteriopathy, Pediatric Stroke, Arteriopathy Trial in San Francisco (methylprednisolone, prednisolone,
Not yet recruiting
- Focal Cerebral Arteriopathy
- +3 more
- methylprednisolone, prednisolone, prednisone
-
San Francisco, CaliforniaUniversity of California San Francisco
Sep 8, 2023
Diffuse Large B-cell Lymphoma (DLBCL) Trial in Westbury (Odronextamab, Rituximab, Cyclophosphamide)
Recruiting
- Diffuse Large B-cell Lymphoma (DLBCL)
- Odronextamab
- +5 more
-
Westbury, New YorkClinical Research Alliance Inc
Oct 13, 2023
DLBCL, High Grade B-Cell Lymphoma w/MYC & BCL2 or BCL6 Rearrangements, High Grade B-Cell Lymphoma w/MYC, BCL2 & BCL6
Recruiting
- Diffuse Large B-Cell Lymphoma
- +2 more
- Prednisone
- +6 more
-
Tampa, Florida
- +1 more
Jan 12, 2022
Leukemia, Lymphocytic, Lymphoblastic Lymphoma, T-cell Lymphoma Trial in United States (Palbociclib, Cytarabine, Methotrexate)
Active, not recruiting
- Leukemia, Lymphocytic
- +5 more
- Palbociclib
- +8 more
-
Birmingham, Alabama
- +18 more
Feb 25, 2022
B Acute Lymphoblastic Leukemia Trial (procedure, biological, drug, radiation)
Not yet recruiting
- B Acute Lymphoblastic Leukemia
- Biospecimen Collection
- +19 more
- (no location specified)
Nov 8, 2023
Steroid-Sensitive Nephrotic Syndrome Trial in Shanghai (Prednisolone, Placebo)
Withdrawn
- Steroid-Sensitive Nephrotic Syndrome
- Prednisolone
- Placebo
-
Shanghai, Shanghai, China
- +3 more
Dec 14, 2020
Chronic GVHD Trial in Duarte (Belumosudil, Placebo, Prednisone)
Recruiting
- Chronic Graft Versus Host Disease
- Belumosudil
- +3 more
-
Duarte, CaliforniaCity of Hope Site Number : 8400001
Nov 23, 2023